Website Search
ID 1182

Glutamate Hypothesis of Schizophrenia

Description:
Professor Jeffrey Lieberman discusses the glutamate hypothesis of schizophrenia. The drug PCP acts on glutamate receptors, producing schizophrenia-like symptoms.
Transcript:
The second neurochemical hypothesis of schizophrenia is the glutamate hypothesis. Now glutamate is also a neurotransmitter. It's a chemical that is in the brain that is secreted into synapses and facilitates nerve impulse propagation. Glutamate stimulates a receptor, a group of receptors. Now there is a recreational drug that is frequently used called PCP, phencyclidine, angel dust. And it was observed that this drug, when people take it, makes them have symptoms, makes them act like they have schizophrenia. Turns out that PCP acts at one of the receptors that glutamate stimulates to block the affects of glutamate. As a result of that, we now believe that one of the reasons why schizophrenia occurs is because people with schizophrenia have a deficiency or a defect in this receptor and the receptor cannot be properly stimulated by glutamate.
Keywords:
schizophrneia, glutamate, hypothesis, PCP, phencyclidine, neurotransmitter, synapse, schizophrenia, hypothesis, neurotransmitter, receptor, jeffrey, lieberman,
Downloads:
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

814. Dopamine Hypothesis of Schizophrenia
Professor Jeffrey Lieberman discusses the dopamine hypothesis, the predominant neurochemical theory of schizophrenia.
1183. Serotonin Hypothesis of Schizophrenia
Professor Jeffrey Lieberman discusses the serotonin hypothesis of schizophrenia. Drugs such as LSD and ecstasy block serotonin and produce schizophrenia-like symptoms.
1173. Glutamate and Schizophrenia
Professor Daniel Weinberger discusses evidence from a number of research areas that highlight the importance of the neurotransmitter glutamate in schizophrenia.
2226. Schizophrenia
An overview of schizophrenia-related content on Genes to Cognition Online.
1211. What is NMDA?
Professor Seth Grant explains that NMDA is an amino acid derivative very similar to glutamate - the brain's primary excitatory neurotransmitter.
510. GRM3 Gene
Metabotropic Glutamate Receptor-3 (GRM3) is a candidate gene for schizophrenia.
1185. Schizophrenia - Typical and Atypical Drugs
Professor Jeffrey Lieberman discusses the differences between typical and atypical drugs that are used to treat schizophrenia.
1106. Phosphorylation and Synaptic Plasticity
Professor Tom O'Dell comments that phosphorylation plays a crucial role in synaptic plasticity.
815. Brain Cells in Schizophrenia - Faulty Circuits?
Professor Jeffrey Lieberman discusses the hypothesis that schizophrenia is caused by a group of genes producing abnormalities in brain development.
1392. Biochemistry of Depression
Doctor Jon Lieberman discusses three neurotransmitters that have been associated with depression - dopamine, serotonin, and norepinephrine.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving